Double maintains 1 strategies that include TMCI - Treace Medical Concepts, Inc.
Current Value
$6.701 Year Return
Current Value
$6.701 Year Return
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
SMDV | 55.07% | $663.17M | 0.4% |
EES | 54.75% | $588.44M | 0.38% |
KRE | 54.02% | $3.59B | 0.35% |
BSVO | 53.59% | $1.40B | 0.47% |
XSVM | 53.48% | $603.10M | 0.37% |
GSSC | 53.38% | $538.65M | 0.2% |
IWN | 53.35% | $11.10B | 0.24% |
KBE | 52.97% | $1.50B | 0.35% |
VIOV | 52.49% | $1.27B | 0.1% |
IJS | 52.43% | $6.27B | 0.18% |
TPSC | 52.35% | $202.13M | 0.52% |
SLYV | 52.33% | $3.75B | 0.15% |
VIOO | 52.32% | $2.88B | 0.1% |
DES | 52.18% | $1.86B | 0.38% |
FYX | 52.04% | $811.75M | 0.6% |
RZV | 52.03% | $200.54M | 0.35% |
IWM | 51.88% | $63.95B | 0.19% |
SPSM | 51.88% | $11.14B | 0.03% |
IJR | 51.86% | $79.01B | 0.06% |
VTWO | 51.66% | $12.07B | 0.07% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CAC | 59.10% | $701.27M | +25.31% | 4.06% |
QLYS | 57.53% | $4.94B | -9.17% | 0.00% |
USPH | 56.88% | $1.19B | -26.33% | 2.24% |
CTBI | 56.60% | $962.41M | +20.77% | 3.54% |
BY | 55.41% | $1.25B | +14.29% | 1.40% |
HWC | 55.37% | $4.88B | +18.90% | 2.90% |
PPBI | 55.01% | $2.18B | -4.30% | 5.92% |
FULT | 54.68% | $3.33B | +4.75% | 3.84% |
HOPE | 54.46% | $1.35B | -2.94% | 5.31% |
OCFC | 54.46% | $1.03B | +10.68% | 4.51% |
IBOC | 54.45% | $4.08B | +8.49% | 2.06% |
PEBO | 54.45% | $1.11B | +1.87% | 5.20% |
KMT | 54.44% | $1.64B | -17.26% | 3.71% |
ASB | 54.43% | $4.03B | +9.65% | 3.72% |
BHLB | 54.31% | $1.24B | +14.49% | 3.41% |
MBWM | 54.25% | $752.01M | +15.92% | 3.11% |
IOSP | 53.95% | $2.20B | -32.27% | 1.77% |
FBK | 53.90% | $2.11B | +18.19% | 1.57% |
NWBI | 53.66% | $1.62B | +11.83% | 6.30% |
CHCO | 53.60% | $1.79B | +18.59% | 2.51% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
BTAL | -31.33% | $361.41M | 1.43% |
VIXY | -30.02% | $109.64M | 0.85% |
TAIL | -24.33% | $140.49M | 0.59% |
FXY | -16.75% | $838.61M | 0.4% |
SGOV | -13.21% | $45.91B | 0.09% |
JMST | -11.90% | $3.65B | 0.18% |
IVOL | -11.39% | $353.94M | 1.02% |
IBTF | -10.92% | $2.12B | 0.07% |
XONE | -10.71% | $603.24M | 0.03% |
UDN | -10.32% | $137.74M | 0.78% |
TBIL | -10.00% | $5.76B | 0.15% |
IBD | -9.99% | $380.12M | 0.43% |
FTSM | -9.96% | $6.54B | 0.45% |
ULST | -9.10% | $637.77M | 0.2% |
CGSM | -9.09% | $658.61M | 0.25% |
TFLO | -9.05% | $7.06B | 0.15% |
FXE | -8.48% | $525.40M | 0.4% |
XHLF | -8.37% | $1.46B | 0.03% |
XBIL | -8.35% | $782.40M | 0.15% |
BWX | -8.21% | $1.41B | 0.35% |
Name | Correlation | AUM | Expense Ratio |
---|---|---|---|
IBMP | -0.01% | $531.75M | 0.18% |
JMBS | -0.02% | $5.40B | 0.22% |
BSMR | 0.02% | $245.57M | 0.18% |
GNMA | 0.03% | $355.60M | 0.1% |
IYK | -0.05% | $1.48B | 0.4% |
JBND | -0.08% | $1.92B | 0.25% |
NEAR | -0.09% | $3.26B | 0.25% |
NUBD | 0.09% | $388.33M | 0.16% |
VTEB | -0.12% | $35.64B | 0.03% |
COM | -0.14% | $222.08M | 0.72% |
FUTY | 0.14% | $1.76B | 0.084% |
VTIP | 0.18% | $14.78B | 0.03% |
PALL | -0.24% | $336.74M | 0.6% |
OWNS | 0.26% | $134.57M | 0.3% |
USCI | -0.28% | $230.94M | 1.07% |
FLMI | -0.29% | $649.76M | 0.3% |
VPU | 0.30% | $6.75B | 0.09% |
PDBC | 0.32% | $4.43B | 0.59% |
IBDQ | 0.35% | $3.08B | 0.1% |
BKAG | 0.36% | $1.86B | 0% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CBOE | -22.97% | $22.95B | +20.67% | 1.12% |
PACS | -18.00% | $1.65B | -62.33% | 0.00% |
CME | -15.95% | $98.74B | +28.80% | 3.84% |
K | -14.27% | $28.49B | +32.17% | 2.77% |
AMT | -12.78% | $99.10B | +8.59% | 3.09% |
CL | -12.30% | $72.64B | -5.18% | 2.25% |
PM | -11.95% | $263.27B | +68.03% | 3.17% |
AEP | -11.90% | $54.28B | +9.80% | 3.61% |
DOGZ | -11.36% | $231.95M | +120.05% | 0.00% |
UL | -11.26% | $154.65B | +14.37% | 3.06% |
SO | -11.12% | $96.04B | +10.08% | 3.29% |
AVNW | -10.96% | $263.49M | -34.51% | 0.00% |
DRD | -10.16% | $1.23B | +63.69% | 2.01% |
PG | -9.77% | $380.78B | -3.25% | 2.51% |
TEF | -9.20% | $27.20B | +8.80% | 6.44% |
GIS | -8.95% | $29.79B | -23.81% | 4.42% |
ED | -8.65% | $36.75B | +5.26% | 3.28% |
NEE | -8.26% | $153.47B | -2.43% | 2.84% |
TU | -8.14% | $23.77B | -4.62% | 7.19% |
FMTO | -8.02% | $45.74M | -99.96% | 0.00% |
Name | Correlation | Market Cap | Return % (1 Year) | Div Yield % |
---|---|---|---|---|
CREG | -0.02% | $16.80M | -32.73% | 0.00% |
SYPR | 0.05% | $37.69M | +21.48% | 0.00% |
OSCR | 0.08% | $4.22B | -25.24% | 0.00% |
GDS | -0.09% | $5.00B | +186.46% | 0.00% |
GHI | -0.20% | $272.58M | -23.91% | 12.67% |
AEE | 0.23% | $26.17B | +29.27% | 2.81% |
TAK | 0.23% | $44.06B | +5.18% | 2.33% |
BVN | -0.24% | $3.68B | -15.25% | 0.00% |
IFF | 0.27% | $19.47B | -22.18% | 2.09% |
BULL | 0.29% | $5.67B | +11.22% | 0.00% |
HUSA | -0.30% | $9.73M | -55.71% | 0.00% |
DTE | 0.30% | $28.28B | +16.72% | 3.10% |
CLVT | -0.32% | $2.94B | -30.26% | 0.00% |
BEEM | 0.33% | $30.53M | -68.83% | 0.00% |
AZN | -0.35% | $210.76B | -11.79% | 2.28% |
MKC | 0.35% | $20.04B | +0.35% | 2.35% |
BTI | -0.36% | $90.76B | +31.13% | 7.29% |
AHR | 0.40% | $5.58B | +144.10% | 2.86% |
PEG | -0.46% | $39.14B | +5.69% | 3.09% |
CMTL | -0.48% | $50.48M | -14.43% | 0.00% |
Finnhub
LOS ANGELES, May 16, 2025 /PRNewswire/ -- Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Treace Medical...
Finnhub
Faruqi & Faruqi, LLP Securities Litigation Partner James Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Treace Medical To Contact Him Directly To Discuss Their OptionsIf you...
Finnhub
NEW YORK, May 16, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Treace Medical Concepts, Inc. of a class action securities lawsuit. ...
Finnhub
NEW YORK, May 15, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Treace Medical Concepts, Inc. . ...
Finnhub
SAN DIEGO, May 14, 2025 /PRNewswire/ -- Robbins LLP reminds stockholders that a class action was filed on behalf of all persons and entities that purchased or otherwise acquired Treace Medical...
Finnhub
NEW YORK, May 13, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor...